Market Research Logo

Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2017

Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Ovarian Cancer patients study in a new report ‘Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Ovarian Cancer epidemiology, Ovarian Cancer diagnosed patients, and Ovarian Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Ovarian Cancer derived from epidemiological analysis, percentage of patients diagnosed with Ovarian Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Ovarian Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Ovarian Cancer prevalence, Ovarian Cancer diagnosis rate, and Ovarian Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Ovarian Cancer Patient Flow
  • Ovarian Cancer Prevalence
  • Ovarian Cancer Diagnosed Patients
  • Ovarian Cancer Treated Patients


1. Ovarian Cancer: Disease Definition
2. Global Ovarian Cancer Patient Flow
2A. Global Ovarian Cancer Prevalence
2B. Global Ovarian Cancer Diagnosed Patients
2C. Global Ovarian Cancer Treated Patients
3. Ovarian Cancer Patient Flow in the US
3A. Ovarian Cancer Prevalence in the US
3B. Ovarian Cancer Diagnosed Patients in the US
3C. Ovarian Cancer Treated Patients in the US
4. Ovarian Cancer Patient Flow in Europe
4A. Ovarian Cancer Prevalence in Europe
4B. Ovarian Cancer Diagnosed Patients in Europe
4C. Ovarian Cancer Treated Patients in Europe
5. Ovarian Cancer Patient Flow in Germany
5A. Ovarian Cancer Prevalence in Germany
5B. Ovarian Cancer Diagnosed Patients in Germany
5C. Ovarian Cancer Treated Patients in Germany
6. Ovarian Cancer Patient Flow in France
6A. Ovarian Cancer Prevalence in France
6B. Ovarian Cancer Diagnosed Patients in France
6C. Ovarian Cancer Treated Patients in France
7. Ovarian Cancer Patient Flow in Spain
7A. Ovarian Cancer Prevalence in Spain
7B. Ovarian Cancer Diagnosed Patients in Spain
7C. Ovarian Cancer Treated Patients in Spain
8. Ovarian Cancer Patient Flow in Italy
8A. Ovarian Cancer Prevalence in Italy
8B. Ovarian Cancer Diagnosed Patients in Italy
8C. Ovarian Cancer Treated Patients in Italy
9. Ovarian Cancer Patient Flow in UK
9A. Ovarian Cancer Prevalence in UK
9B. Ovarian Cancer Diagnosed Patients in UK
9C. Ovarian Cancer Treated Patients in UK
10. Ovarian Cancer Patient Flow in Japan
10A. Ovarian Cancer Prevalence in Japan
10B. Ovarian Cancer Diagnosed Patients in Japan
10C. Ovarian Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Ovarian Cancer Patient Flow, 2016
Table 2: Global Ovarian Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Ovarian Cancer Patient Flow in the US, 2016
Table 4: Ovarian Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Ovarian Cancer Patient Flow in Europe, 2016
Table 6: Ovarian Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Ovarian Cancer Patient Flow in Germany, 2016
Table 8: Ovarian Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Ovarian Cancer Patient Flow in France, 2016
Table 10: Ovarian Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Ovarian Cancer Patient Flow in Spain, 2016
Table 12: Ovarian Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Ovarian Cancer Patient Flow in Italy, 2016
Table 14: Ovarian Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Ovarian Cancer Patient Flow in UK, 2016
Table 16: Ovarian Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Ovarian Cancer Patient Flow in Japan, 2016
Table 18: Ovarian Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Ovarian Cancer Patient Flow, 2016
Figure 2: Global Ovarian Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Ovarian Cancer Patient Flow in the US, 2016
Figure 4: Ovarian Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Ovarian Cancer Patient Flow in Europe, 2016
Figure 6: Ovarian Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Ovarian Cancer Patient Flow in Germany, 2016
Figure 8: Ovarian Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Ovarian Cancer Patient Flow in France, 2016
Figure 10: Ovarian Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Ovarian Cancer Patient Flow in Spain, 2016
Figure 12: Ovarian Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Ovarian Cancer Patient Flow in Italy, 2016
Figure 14: Ovarian Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Ovarian Cancer Patient Flow in UK, 2016
Figure 16: Ovarian Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Ovarian Cancer Patient Flow in Japan, 2016
Figure 18: Ovarian Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report